Eybna is a global leader in the research and development of cannabis terpene based solutions, with the mission of bringing the benefits of cannabis to more patients, by isolating the medicinal properties found in different strains and providing cannabis medicine that is tailored to treat specific medical conditions.
While common practice is to selectively breed and genetically modify cannabis in order to reach specific traits, Eybna is leading a revolutionary new approach.
By mapping and isolating all the building blocks of cannabis and studying their independent and synergistic properties, with emphasis on terpenes that have recently been found to account for many of the effects induced by each strain. Eybna is able to construct new formulations that hold the different medical benefits of cannabis.
To date, with access to a focus group of over 2000 patients, Eybna is already seeing very positive results and it is not far before Eybnas first formulations are released, changing the lives of millions of patients worldwide.